Bracco Diagnostics Inc Careers in Monroe Township, NJ

The Bracco Group, established in 1927, is a multinational healthcare group, which operates in 90 countries worldwide. Bracco extended the range of its offering over the years, thanks to acquisitions and strong innovation capabilities, entering the Magnetic Resonance imaging (MRI) market with ProHance® (gadoteridol) injection, 279.3 mg/mL and MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL, consolidating its leadership in X-Ray/CT with Isovue® (iopamidol injection) and entering the Nuclear Medicine segment, with a leading position in fast growing niche areas of Positron Emission Tomography (PET), Cardiology, and Hepatobiliary Imaging. And it continues to devote considerable effort and substantial resources to create and develop innovative products and solutions addressing unmet or poorly met medical needs.